Status:
UNKNOWN
Evaluation the Effectiveness of Ru-Yi-Jin-Huang Powder for the Radiation-induced Dermatitis.
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Radiation Dermatitis
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
Radiation-induced dermatitis is the most common complication of radiotherapy for cancer treatment. However, there is no satisfactory management to deal with the problem. Ru-Yi-Jin-Huang Powder is one ...
Detailed Description
The common management of head and neck cancer are concurrent chemoradiotherapy (CCRT) after surgical section. Radiation-induced dermatitis is the most common complication of radiotherapy for cancer, a...
Eligibility Criteria
Inclusion
- stage 3 or 4 of head and neck cancer or nasopharyngeal cancer with pathological confirmed malignancy undergoing concurrent chemoradiotherapy more than 20 times or radiation dermatitis \> CTCAE grade 2.
- more than 18 years old.
- VAS score \> 6 with poor response to narcotics.
- estimated survival time of \> 6 months.
- be suitable for TCM topical treatment after evaluation by TCM physicians.
- willingness to joint this trial and sign consent form of study.
Exclusion
- non-head and neck cancer or have not receive CCRT.
- not be suitable for Ru-Yi-Jin-Huang topical treatment after TCM physicians evaluation.
- history of allergy to TCM topical use.
- poor conscious to answer questionnaires.
- pregnancy.
- KPS \< 30.
Key Trial Info
Start Date :
May 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04888234
Start Date
May 8 2021
End Date
July 30 2022
Last Update
May 17 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.